4.7 Article

Particle Tracking of Intracellular Trafficking of Octaarginine-modified Liposomes: A Comparative Study With Adenovirus

期刊

MOLECULAR THERAPY
卷 18, 期 5, 页码 955-964

出版社

CELL PRESS
DOI: 10.1038/mt.2010.33

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
  2. Japan Society for the Promotion of Science (JSPS)
  3. Konica Minolta Imaging Science Foundation

向作者/读者索取更多资源

It is previously reported that octaarginine (R8)-modified liposome (R8-Lip) was taken up via macropinocytosis, and subsequently delivered to the nuclear periphery. In the present study, we investigated the mechanism for the cytoplasmic transport of R8-Lips, comparing with that for adenovirus. Treatment with microtubule-disruption reagent (nocodazole) inhibited the transfection activity of plasmid DNA (pDNA)-encapsulating R8-Lip more extensively than that of adenovirus. The directional transport of R8-Lips along green fluorescent protein (GFP)-tagged microtubules was observed; however, the velocity was slower than those for adenovirus or endosomes that were devoid of R8-Lips. These directional motions were abrogated in R8-Lips by nocodazole treatment, whereas adenovirus continued to undergo random motion. This finding suggests that the nuclear access of R8-Lip predominantly involves microtubule-dependent transport, whereas an apparent diffusive motion is also operative in nuclear access of adenovirus. Furthermore, quantum dot-labeled pDNA underwent directional motion concomitantly with rhodamine-labeled lipid envelopes, indicating that the R8-Lips were subject to microtubule-dependent transport in the intact form. Dual particle tracking of carriers and endosomes revealed that R8-Lip was directionally transported, associated with endosomes, whereas this occurs after endosomal escape in adenovirus. Collectively, the findings reported herein indicate that vesicular transport is a key factor in the cytoplasmic transport of R8-Lips.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Toxoplasma gondii GRA15 DNA Vaccine with a Liposomal Nanocarrier Composed of an SS-Cleavable and pH-Activated Lipid-like Material Induces Protective Immunity against Toxoplasmosis in Mice

Tanjila Hasan, Ryo Kawanishi, Hidetaka Akita, Yoshifumi Nishikawa

Summary: ssPalmE-LNP is an effective carrier for DNA vaccines against protozoan infections, leading to increased survival rates and antibody production in mice. Further immunological studies are needed to explore the mechanism of protective immunity induced by ssPalmE-LNPTgGRA15.

VACCINES (2022)

Article Pharmacology & Pharmacy

Formation of reactive metabolites of benzbromarone in humanized- liver mice

Naoki Cho, Hiroshi Suemizu, Hidetaka Kamimura, Tomoyuki Ohe, Fumi Ito, Hidetaka Akita, Kaoru Kobayashi

Summary: This study used a humanized-liver mouse model to investigate the pharmacokinetic profiles of benzbromarone and the generation of reactive metabolites. The results showed that the metabolic profiles of benzbromarone in humanized-liver mice were similar to those in humans, and the detected reactive metabolites were associated with benzbromarone-induced hepatotoxicity.

DRUG METABOLISM AND PHARMACOKINETICS (2022)

Article Medicine, Research & Experimental

Human Immortalized Cell-Based Blood-Brain Barrier Spheroid Models Offer an Evaluation Tool for the Brain Penetration Properties of Macromolecules

Keita Kitamura, Ayaka Okamoto, Hanae Morio, Ryuto Isogai, Ryo Ito, Yoshiyuki Yamaura, Saki Izumi, Takafumi Komori, Shingo Ito, Sumio Ohtsuki, Hidetaka Akita, Tomomi Furihata

Summary: This study characterizes the ability of the hiMCS-BBB models to evaluate receptor-mediated transcytosis (RMT)-mediated blood-brain barrier (BBB) penetration properties of middle/macromolecules. The results show that the hiMCS-BBB models have the potential to provide valuable tools for exploring and identifying middle/macromolecules with excellent BBB permeability levels.

MOLECULAR PHARMACEUTICS (2022)

Article Chemistry, Multidisciplinary

Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA

Hiroki Tanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Takashi Tadokoro, Katsumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita

Summary: There is a growing demand by researchers to test whether their own biological findings might be applicable for use in mRNA-based therapeutics, but the equipment and know-how required for manufacturing such nanoparticles is often inaccessible. A simple method for preparing mRNA-LNPs is prerequisite to encourage more innovation in mRNA therapeutics. This study reports on a method for encapsulating IVT-mRNA into LNPs by rehydrating a Ready-to-Use empty freeze-dried LNP formulation with IVT-mRNA solution followed by heating, and the resulting mRNA-LNPs had a similar structure compared to the mRNA-LNPs prepared by conventional microfluidic mixing. In vivo genome editing using these mRNA-LNPs was achieved.

ACS NANO (2023)

Article Chemistry, Multidisciplinary

siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles

Yu Sakurai, Keito Yoshikawa, Kenta Arai, Akira Kazaoka, Shigeki Aoki, Kousei Ito, Yuta Nakai, Kota Tange, Tomomi Furihata, Hiroki Tanaka, Hidetaka Akita

Summary: This study targets lymphatic endothelial cells (LEC) using ionizable lipid-formulated nanoparticles (LNPs) complexed with Apolipoprotein E (ApoE). The LNPs are taken up by LECs in an ApoE-dependent manner, as shown in in vitro studies. Modifying the surface of the LNPs with a high density of PEG-conjugated lipids with short acyl chains enables effective targeting of LECs after subcutaneous administration. This approach significantly inhibits the expression of the LEC marker VEGFR3.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Reactivation of Anticancer Immunity by Resetting Interorgan Crosstalk in Immune-Suppressive Cells with a Nanoparticulated Anti-Inflammatory Drug

Mizuki Doi, Hiroki Tanaka, Takara Ohoto, Naoya Miura, Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita

Summary: The reactivation of anticancer immunity using immune checkpoint inhibitors (ICIs) is a crucial aspect in cancer immunotherapy. However, the low objective response rate (<40%) of ICIs remains a major challenge. This study demonstrates that myeloid-derived suppressor cells (MDSCs) can be depleted by delivering synthetic glucocorticoid dexamethasone to phagocytic cells in the spleen using lipid nanoparticles. Additionally, the nanoparticulated dexamethasone exhibits a synergistic anticancer effect with ICIs.
Article Engineering, Biomedical

Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles

Masaki Gomi, Yu Sakurai, Minami Sato, Hiroki Tanaka, Yumi Miyatake, Koichi Fujiwara, Mizuki Watanabe, Satoshi Shuto, Yuta Nakai, Kota Tange, Hiroto Hatakeyama, Hidetaka Akita

Summary: This study reports the development of a new lipid nanoparticle (LNP) that efficiently delivers messenger RNA (mRNA) to secondary lymphoid tissues. A microfluidic technique was used to incorporate alcohol-soluble phosphatidylserine (PS) derivatives, designed to target immune cells, into LNPs with high scalability and reproducibility. The resulting PS-loaded LNP delivered mRNA to the spleen more efficiently than a control LNP. Sub-organ analysis revealed extensive uptake of the PS-loaded LNP by tissue-resident macrophages in the red pulp and marginal zone of the spleen. Therefore, the PS-loaded LNP described in this study holds promise for clinical applications involving mRNA delivery to the spleen.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Chemistry, Analytical

Label-Free Evaluation of Maturation and Hepatotoxicity of Human iPSC-Derived Hepatocytes Using Hyperspectral Raman Imaging

Menglu Li, Yukiko Ueyama-Toba, Matthew Lindley, Gunganist Kongklad, Yasunori Nawa, Yasuaki Kumamoto, Seiichi Ishida, Yasunari Kanda, Satoshi Fujita, Hiroyuki Mizuguchi, Katsumasa Fujita

Summary: To promote the clinical application of hiPSC-derived hepatocytes, a label-free Raman microscopy method is used to monitor regenerative processes and assess differentiation efficiency. The method has successfully identified intracellular biomolecules in live samples and compared the phenotypes of hiPSC-derived hepatocytes with HepaRG and commercially available iCell hepatocytes. The study also explored the use of Raman imaging as a hepatotoxicity assay, demonstrating its potential for quality control and hepatotoxicity screening.

ANALYTICAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions

Jumpei Inui, Yukiko Ueyama-Toba, Seiji Mitani, Hiroyuki Mizuguchi

Summary: A method has been developed to dissociate, cryopreserve, and reseed human induced pluripotent stem cell-derived hepatocyte-like cells (HLCs) without loss of their functions. This technology enables the availability of cryopreserved HLCs for drug discovery research.

PLOS ONE (2023)

Article Biology

miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells

Eiko Sakai, Tsutomu Imaizumi, Ruruka Suzuki, Marcos Taracena-Gandara, Toshiki Fujimoto, Fuminori Sakurai, Hiroyuki Mizuguchi

Summary: Non-alcoholic liver disease (NAFLD) is caused by excessive fat accumulation in the liver and miR-27b has been found to play a crucial role in NAFLD development by targeting genes involved in lipid metabolism. This study identified MAIP1 as a direct target of miR-27b and showed that overexpression of MAIP1 can ameliorate lipid accumulation induced by miR-27b. Additionally, decreased Maip1 expression was observed in mice fed a high-fat diet, suggesting its involvement in fatty liver condition and its potential as a therapeutic target for NAFLD.

COMMUNICATIONS BIOLOGY (2023)

Article Biochemistry & Molecular Biology

A Lipid Nanoparticle-Based Method for the Generation of Liver-Specific Knockout Mice

Sumiyo Morita, Takuro Horii, Mika Kimura, Ryosuke Kobayashi, Hiroki Tanaka, Hidetaka Akita, Izuho Hatada

Summary: Knockout mice are important tools for studying the normal function of genes. Liver-specific conditional knockout mice can be generated using lipid nanoparticles, which offers a more convenient method compared to traditional approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Development of an Alcohol Dilution-Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability

Daiki Shirane, Hiroki Tanaka, Yu Sakurai, Sakura Taneichi, Yuta Nakai, Kota Tange, Itsuko Ishii, Hidetaka Akita

Summary: The lipid nanoparticle (LNP) is a promising nanotechnology for delivering RNA molecules, including siRNA and mRNA. LNPs encoding the antigen protein of SARS-CoV-2 have been approved as mRNA vaccines against the disease. LNP formulations are generally metastable, and their properties can shift towards a more stable state during long-term storage. To enable easier storage, a one-pot method was used to prepare freeze-dried formulations of mRNA-LNPs that can be stored at 4°C for at least 4 months.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery

Xuan Du, Erica Yada, Yuki Terai, Takuya Takahashi, Hideyuki Nakanishi, Hiroki Tanaka, Hidetaka Akita, Keiji Itaka

Summary: This study compared the performance of nanomicelles and LNPs in mRNA delivery. The nanomicelles showed relatively sustained protein production and reduced inflammation, making them suitable for therapeutic purposes, while LNPs exhibited rapid mRNA expression and a potent immune response, making them suitable for vaccine purposes. These results provide support for further optimization of mRNA delivery systems tailored for specific purposes.

PHARMACEUTICS (2023)

Article Chemistry, Medicinal

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis

Masaki Gomi, Yuka Nakayama, Yu Sakurai, Ryotaro Oyama, Koki Iwasaki, Mizuki Doi, Yi Liu, Mizuho Hori, Himeka Watanabe, Kohei Hashimoto, Hiroki Tanaka, Kota Tange, Yuta Nakai, Hidetaka Akita

Summary: This study investigates the delivery of mRNA encoding autoantigens to the spleen using lipid nanoparticles (LNPs) containing phosphatidylserine (PS). The expressed MOG35-55 antigens induce immune tolerance and could potentially be used as a treatment for experimental autoimmune encephalitis (EAE).

PHARMACEUTICALS (2023)

Review Chemistry, Organic

Molecular Design of In-cell Environment-responsive Lipid Like Materials for the Control of Intracellular Trafficking and Collapse

Hiroki Tanaka, Hidetaka Akita

Summary: Specialized medicine is now expanding from low-molecular drugs to recombinant proteins, antibodies, and nucleic acids. Among them, RNA therapy is growing worldwide as an alternative gene complement approach. The use of short nucleic acids such as siRNA and miRNA to regulate disease-related genes shows promising results in the field of medicine.

JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN (2022)

暂无数据